Brokerages Set Lemonade, Inc. (NYSE:LMND) Target Price at $20.50

Shares of Lemonade, Inc. (NYSE:LMND - Get Free Report) have earned a consensus rating of "Reduce" from the seven brokerages that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $20.17.

Separately, Jefferies Financial Group cut their price target on Lemonade from $15.00 to $14.00 and set an "underperform" rating on the stock in a research note on Wednesday.

Insider Transactions at Lemonade

In related news, CFO Timothy E. Bixby sold 2,050 shares of the business's stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.24, for a total transaction of $37,392.00. Following the completion of the sale, the chief financial officer now owns 271,552 shares of the company's stock, valued at $4,953,108.48. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 12.50% of the company's stock.

Institutional Trading of Lemonade

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Marshall Wace LLP acquired a new stake in Lemonade during the 2nd quarter worth about $14,181,000. General Equity Holdings LP bought a new position in shares of Lemonade in the second quarter worth about $5,198,000. GSA Capital Partners LLP acquired a new position in shares of Lemonade during the first quarter worth approximately $3,100,000. Millennium Management LLC boosted its holdings in Lemonade by 388.7% in the 2nd quarter. Millennium Management LLC now owns 165,689 shares of the company's stock valued at $2,734,000 after purchasing an additional 131,784 shares during the period. Finally, Caxton Associates LP bought a new stake in shares of Lemonade in the second quarter valued at about $737,000. Institutional investors own 80.30% of the company's stock.

Lemonade Stock Performance

LMND traded up $0.62 on Wednesday, hitting $16.35. The company had a trading volume of 1,280,531 shares, compared to its average volume of 1,592,922. The stock has a market capitalization of $1.15 billion, a price-to-earnings ratio of -5.16 and a beta of 1.77. Lemonade has a 12-month low of $10.27 and a 12-month high of $24.55. The stock has a fifty day moving average price of $17.27 and a 200-day moving average price of $17.40.

Lemonade (NYSE:LMND - Get Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported ($0.81) EPS for the quarter, beating the consensus estimate of ($0.88) by $0.07. Lemonade had a negative return on equity of 30.34% and a negative net margin of 44.24%. The company had revenue of $122.00 million for the quarter, compared to analyst estimates of $121.77 million. During the same period last year, the company earned ($0.97) earnings per share. Lemonade's quarterly revenue was up 16.6% compared to the same quarter last year. Analysts forecast that Lemonade will post -3.03 EPS for the current fiscal year.

Lemonade Company Profile

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.